Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Reproduction and Fertility
|
May 1, 1973
Differential effects of oestrogen on the uptake of nucleic acid precursors by mouse blastocysts in vitro
J A Harrer, H H Lee
The British Journal of Dermatology
|
April 23, 2020
Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab
A Harrer, R Lang, P Kölblinger
The Journal of Investigative Dermatology
|
February 1, 1986
Leu-3/T4 expression on epidermal Langerhans cells in normal and diseased skin
V Groh, M Tani, A Harrer, et al.
Multiple Sclerosis and Related Disorders
|
January 8, 2021
Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribine
R F Radlberger, I Sakic, T Moser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 4, 2011
Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies
G Pilz, A Harrer, K Oppermann, et al.
Acta Neurologica Scandinavica
|
September 17, 2013
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
P Wipfler, A Harrer, G Pilz, et al.
Journal of Neurology
|
August 10, 2012
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis
P Wipfler, A Heikkinen, A Harrer, et al.
Multiple Sclerosis and Related Disorders
|
April 17, 2015
High-dose intravenous interferon-beta in multiple sclerosis patients with high-titer neutralizing antibodies (HINABS II) - A pilot study
H Hegen, M Guger, A Harrer, et al.
Journal of Neurology
|
July 25, 2021
Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events
C O Sullivan, F Zach, T Moser, et al.
Clinical and Experimental Immunology
|
April 25, 2013
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis
J Sellner, W Koczi, A Harrer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Reproduction and Fertility
|
May 1, 1973
Differential effects of oestrogen on the uptake of nucleic acid precursors by mouse blastocysts in vitro
J A Harrer, H H Lee
The British Journal of Dermatology
|
April 23, 2020
Epitope competition and neutralizing antidrug antibodies: immune monitoring of antiprogrammed death-1 therapies and lessons learned from natalizumab
A Harrer, R Lang, P Kölblinger
The Journal of Investigative Dermatology
|
February 1, 1986
Leu-3/T4 expression on epidermal Langerhans cells in normal and diseased skin
V Groh, M Tani, A Harrer, et al.
Multiple Sclerosis and Related Disorders
|
January 8, 2021
Immune phenotyping study revealing caveats regarding a switch from fingolimod to cladribine
R F Radlberger, I Sakic, T Moser, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 4, 2011
Molecular evidence of transient therapeutic effectiveness of natalizumab despite high-titre neutralizing antibodies
G Pilz, A Harrer, K Oppermann, et al.
Acta Neurologica Scandinavica
|
September 17, 2013
Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?
P Wipfler, A Harrer, G Pilz, et al.
Journal of Neurology
|
August 10, 2012
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis
P Wipfler, A Heikkinen, A Harrer, et al.
Multiple Sclerosis and Related Disorders
|
April 17, 2015
High-dose intravenous interferon-beta in multiple sclerosis patients with high-titer neutralizing antibodies (HINABS II) - A pilot study
H Hegen, M Guger, A Harrer, et al.
Journal of Neurology
|
July 25, 2021
Misinterpretation of glioblastoma as ADEM: potentially harmful consequences of over-diagnosis of COVID-19 vaccine-associated adverse events
C O Sullivan, F Zach, T Moser, et al.
Clinical and Experimental Immunology
|
April 25, 2013
Glatiramer acetate attenuates the pro-migratory profile of adhesion molecules on various immune cell subsets in multiple sclerosis
J Sellner, W Koczi, A Harrer, et al.
Page
of 2